These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 9026270)
21. Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis. Johnson EO; Kamilaris TC; Calogero AE; Gold PW; Chrousos GP Eur J Endocrinol; 2005 Jul; 153(1):177-85. PubMed ID: 15994759 [TBL] [Abstract][Full Text] [Related]
22. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat. Rivier C; Vale W J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917 [TBL] [Abstract][Full Text] [Related]
23. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone. Calogero AE; Kamilaris TC; Johnson EO; Tartaglia ME; Chrousos G Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393 [TBL] [Abstract][Full Text] [Related]
24. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Chowdrey HS; Larsen PJ; Harbuz MS; Jessop DS; Aguilera G; Eckland DJ; Lightman SL Br J Pharmacol; 1995 Nov; 116(5):2417-24. PubMed ID: 8581278 [TBL] [Abstract][Full Text] [Related]
25. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal. Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179 [TBL] [Abstract][Full Text] [Related]
26. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats. Huang TS J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537 [TBL] [Abstract][Full Text] [Related]
27. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes. Schwartz MW; Strack AM; Dallman MF Regul Pept; 1997 Oct; 72(2-3):105-12. PubMed ID: 9652969 [TBL] [Abstract][Full Text] [Related]
28. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Chan O; Inouye K; Vranic M; Matthews SG Endocrinology; 2002 May; 143(5):1761-8. PubMed ID: 11956158 [TBL] [Abstract][Full Text] [Related]
29. Apoptosis of acinar cells is involved in chronic pancreatitis in Wbn/Kob rats: role of glucocorticoids. Hashimoto T; Yamada T; Yokoi T; Sano H; Ando H; Nakazawa T; Ohara H; Nomura T; Joh T; Itoh M Pancreas; 2000 Oct; 21(3):296-304. PubMed ID: 11039475 [TBL] [Abstract][Full Text] [Related]
30. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin. Tizabi Y; Aguilera G Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816 [TBL] [Abstract][Full Text] [Related]
31. Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood. Fink G; Robinson IC; Tannahill LA J Physiol; 1988 Jul; 401():329-45. PubMed ID: 2845063 [TBL] [Abstract][Full Text] [Related]
32. Plasma catecholamines do not participate in pituitary-adrenal activation by immobilization stress in rats with transection of nerve fibers to the median eminence. Makara GB; Kvetnansky R; Jezova D; Jindra A; Kakucska I; Oprsalova Z Endocrinology; 1986 Oct; 119(4):1757-62. PubMed ID: 3019642 [TBL] [Abstract][Full Text] [Related]
33. Effect of hypertonic saline on the corticotropin-releasing hormone and arginine vasopressin content of the rat pituitary neurointermediate lobe. Hashimoto K; Suemaru S; Hirasawa R; Takao T; Makino S; Kageyama J; Ogasa T; Ota Z; Kawata M Endocrinol Jpn; 1990 Oct; 37(5):599-606. PubMed ID: 1964896 [TBL] [Abstract][Full Text] [Related]
34. Age-related alterations of hypothalamic-pituitary-adrenal axis function in male Fischer 344 rats. Hauger RL; Thrivikraman KV; Plotsky PM Endocrinology; 1994 Mar; 134(3):1528-36. PubMed ID: 8119195 [TBL] [Abstract][Full Text] [Related]
35. Vasopressin and CRF-ACTH in adrenalectomized and dexamethasone-treated rats. Hashimoto K; Yunoki S; Kageyama J; Ohno N; Takahara J; Ofuji T Neuroendocrinology; 1981 Feb; 32(2):87-91. PubMed ID: 6259547 [TBL] [Abstract][Full Text] [Related]
36. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response. Milanés MV; Laorden ML; Chapleur-Château M; Burlet A Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):603-10. PubMed ID: 9402040 [TBL] [Abstract][Full Text] [Related]
37. Effects of experimental hypothyroidism on the development of the hypothalamo-pituitary-adrenal axis in the rat. Dakine N; Oliver C; Grino M Life Sci; 2000 Oct; 67(23):2827-44. PubMed ID: 11105998 [TBL] [Abstract][Full Text] [Related]
38. Effect of 3 day infusion of ACTH or CRF on the pituitary-adrenal axis. Silberberg S; Funder JW Clin Exp Pharmacol Physiol; 1988 Jan; 15(1):15-21. PubMed ID: 2482798 [TBL] [Abstract][Full Text] [Related]
39. Hypersecretion of corticotrophin-releasing hormone and arginine vasopressin in hypothyroid male rats as estimated with push-pull perfusion. Tohei A; Watanabe G; Taya K J Endocrinol; 1998 Feb; 156(2):395-400. PubMed ID: 9518888 [TBL] [Abstract][Full Text] [Related]
40. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress. Tilders FJ; Berkenbosch F; Vermes I; Linton EA; Smelik PG Fed Proc; 1985 Jan; 44(1 Pt 2):155-60. PubMed ID: 2981737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]